The findings herein demonstrate that dapagliflozin shows great potential in significantly ameliorating the injury of DN and podocytes mediated by relieving cholesterol accumulation via the KLF-5/ABCA1 pathway. This evidence concerns the gene ABCA1 and liver dysplastic nodule.